U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07687485) titled 'Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System' on June 26.

Brief Summary: The objective of this clinical study is to assess the safety and efficacy of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System for the treatment of symptomatic subjects with at least severe tricuspid regurgitation (TR).

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Severe Tricuspid Valve Regurgitation

Intervention: DEVICE: Transcatheter Tricuspid Valve Replacement (TTVR) with Laplace TTVR System

Transcatheter Tricuspid Valve Replacement

DEVICE: Transcatheter Tricus...